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Controlled drug delivery systems are an encouraging solution to some drug disadvantages such as reduced
solubility, deprived biodistribution, tissue damage, fast breakdown of the drug, cytotoxicity, or side effects.
Self-ordered nanoporous anodic alumina is an auspicious material for drug delivery due to its biocompatibility, stability,
and controllable pore geometry. Its use in drug delivery applications has been explored in several fields, including
therapeutic devices for bone and dental tissue engineering, coronary stent implants, and carriers for transplanted cells.
In this work, we have created and analyzed a stimuli-responsive drug delivery system based on layer-by-layer
pH-responsive polyelectrolyte and nanoporous anodic alumina. The results demonstrate that it is possible to
control the drug release using a polyelectrolyte multilayer coating that will act as a gate.
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DoxorubicinBackground
Nearly 90 % of the existing drugs are hydrophobic which
means they cannot be dissolved in the blood. This re-
duces their pharmacological efficiency. On the other
hand, some bioactive agents such as proteins, nucleic
acids, or enzymes administered though oral or intraven-
ous routes can be easily degraded by metabolism or by
enzymatic conditions and are unable to reach the de-
sired sites [1–3]. Increasing the knowledge of materials
at the nanoscale may accelerate the improvement of
drug delivery systems, especially in treating life-
threatening conditions such as cancer and heart disease.
Nanoporous and nanotube carriers with their unique
features such as low-cost fabrication, controllable pore/
nanotube structure, tailored surface chemistry, high sur-
face area, high loading capability, chemical resistivity,
and mechanical rigidity have affianced a special role in
drug delivery technology. Drug release is a process in
which a composite or a device releases a drug in a* Correspondence: lluis.marsal@urv.cat
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the Creative Commons license, and indicate ifcontrolled way and is subjected to absorption, distribu-
tion, metabolism and excretion (ADME), finally becom-
ing available for pharmacological action. To achieve and
preserve therapeutically effective plasma concentrations,
several doses are needed daily, which may cause signifi-
cant fluctuations in plasma levels. Because of these fluc-
tuations in drug plasma levels, the drug concentration
could fall below the minimum effective concentration or
exceed the minimum toxic concentration. Such changes
result in undesirable side effects or lack of therapeutic
profit to the patient.
Sustained-release and controlled-release drug delivery
systems can reduce the undesired fluctuations of drug
levels, consequently diminishing side effects while im-
proving the therapeutic result of the drug. The terms
sustained release and controlled release refer to two dif-
ferent kinds of drug delivery systems (DDS), although
they are often used interchangeably. Sustained-release
dosage forms are systems that elongate the duration of
the action by reducing the release of the drug and its
pharmacological action. Controlled-release drug systems
are more sophisticated than just simply delaying theis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
e appropriate credit to the original author(s) and the source, provide a link to
changes were made.
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cific release rates within a predetermined time period.
Advantages of controlled release DDS comprise delivery
of a drug to the required site, maintenance of drug levels
within a desired range, reduced side effects, fewer
administrations, and improved patient compliance. The
evolution of delivery systems leads to stimuli-responsive
DDS, whose behavior can be dependent on the environ-
ment where it is applied. In recent years, the pH-
responsive controlled drug delivery systems have
attracted considerable attention because of the acidic
tumoral environment of most cancers and the acidic
environs of wounds [4]. In this work, we propose a DDS
that can be defined as a sustained, controlled and
stimuli-responsive release system due to its capability to
release the drug in a desired rate and responding to pH
changing stimulus.
The DDS we propose is based on nanoporous anodic
alumina (NAA). It was not until the 1990s that re-
searchers discovered that highly ordered nanoporous
structures can be achieved by properly tuning anodiza-
tion conditions including electrolyte composition and
concentration and temperature, as well as anodization
voltage [5]. Some studies have been already performed
in the drug delivery framework using porous materials
[6–8]. Nanoporous anodic alumina is one of the most at-
tractive materials for drug delivery applications since it
has simple and low-cost fabrication and the pore size
and depth can easily be controlled by regulating the ano-
dizing voltage, time, and electrolyte composition. Other
remarkable properties of this material are the chemical
and thermal stability, hardness, high surface area, and
highly ordered pore structure [9, 10]. Some applications
of NAA are to reconstruct or regenerate living tissues
and deal with infections and inflammation as conse-
quence of chirurgical implantation or just for drug
constant administration [11]. Drug depots in the hu-
man body with controlled and retained release are
able to improve quality of life and assist long-termFig. 1 Schematic representation of the alumina pores formation during the
surface. b The first anodization followed by the dissolution of the alumina
anodization on the patterned aluminum creates a perfect ordered NAAtreatments. In addition, the development of those
new and more efficient drug delivery systems solve
conventional drug therapy problems related to limited
drug solubility, lack of selectivity, and unfavorable
pharmacokinetics.
The structure of NAA can be described at a close-
packed hexagonal and perpendicular orientated array of
columnar cells, each containing a central pore, of which
the size and interval can be controlled by changing the
anodization conditions. The drug release from porous
materials is based on molecular diffusion from the pores,
and it is mainly governed by the pore dimensions [12].
Therefore, adjustment of pore diameter and pore depth
has been considered a common strategy to control drug
release performance.
In this study, NAA platforms with a pore diameter of
130 nm and pore depth of 15 μm were used as a model
porous material. In order to realize a controlled drug re-
lease, a pH stimuli-responsive polyelectrolyte layer-by-
layer (LbL) assembly has been used to coat the porous
matrixes. Doxorubicin (DOX), a potent antineoplasic
agent against a wide range of human tumors, was
chosen as a model drug to perform the trials. The poly-
electrolyte multilayer on the surface prevents the early
release of the drug and enables the use of the total en-
hanced surface in the NAA samples. The effect of pH in
the drug release kinetics has been studied and discussed




Ordered nanoporous anodic alumina was prepared by
the two-step anodization method (Fig. 1) [13–15].
Aluminum plates were degreased in acetone and ethanol
to eliminate organic impurities. They were then subse-
quently electropolished (Fig. 1a). Then they were anod-
ized for the first time using a ramp to achieve the
desired voltage. At that moment, the disordered porousanodization process. a The electopolishing procedure creates a plane
wall creates an ordered pattern in the aluminum sheet. c The second
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(Fig. 1b), leaving a highly periodic structure of nano-
concavities [16–19]. At that time, a second anodization
was performed obtaining an ordered and 15-μm deep
alumina porous layer (Fig. 1c). This process is explained
in detail in the supplementary information.
Polyelectrolytes Assembly
In order to cover the nanopore walls with polyelectrolyte
layers, nanoporous anodic alumina was first coated with
3-aminopropyl triethoxysilane (APTES). The positively
charged APTES substrates would allow negatively
charged polyelectrolytes to be attached to the pore walls
(Fig. 2a). For LbL deposition, the NAA substrates were
immersed consecutively into a negatively charged solu-
tion of poly(styrenesulfonate) (PSS, 1 mg/ml in 5 mM
CaCl2 in deionized water) (Fig. 2b) and a positively
charged solution of poly(allylamine hydrocloride) (PAH,
1 mg/ml in 5 mM CaCl2 in deionized water) (Fig. 2c),
alternating rinsing with deionized water between each
immersion. Dipping times in polyelectrolyte solutions
were 30 min and the washing step in deionized water
lasted for 10 min [20]. All the steps were repeated for
two, five, and eight times for obtaining two, five, and
eight bilayers, respectively.
Drug Loading
Positively charged DOX hydrochloride was selected as a
model drug. LbL NAA samples were immersed in 1 mg/
ml DOX solution at pH 2 in the dark at room
temperature overnight (Fig. 2d). Then the DOX solution
was adjusted to pH 8 and the samples were stirred 2 h
in the dark (Fig. 2e). Subsequently, samples were washedFig. 2 Schematic representation of the polyelectrolyte layer-by-layer depos
treatment. b PSS deposition by immersing the APTES treated surface. c PA
in the swollen PEM film at pH 2.0. e DOX confinement due to the PEM laywith deionized water at pH 8. At pH 2, the increased
permeability of the polyelectrolytes film facilitates the
incorporation of DOX inside the PSS/PAH multi-
layers. Then the adjustment of pH at 8 causes the
contraction of the polyelectrolytes and the drug mol-
ecule becomes trapped inside the polyelectrolyte film.
The following washing will remove any nontrapped
DOX molecule.
Drug Release
Samples under test were immersed in phosphate buff-
ered saline (PBS) at pH 7.4 and sodium acetate buffer at
pH 5.2 (Fig. 2f ). Samples were immersed in 0.5 ml of the
corresponding medium and this medium was renewed
at every measurement. Release characteristics depending
on the number of polyelectrolyte layers and on the
pH of the release medium were examined. Release ex-
periments consisted of monitoring the diffusion of
DOX as a function of time after the encapsulation
within the polyelectrolyte coating. For this reason,
fluorescence of the buffers solutions was measured at
regular time intervals. The photoluminescence mea-
surements were taken on a fluorescence spectropho-
tometer with a Xe lamp used as the excitation light
source at room temperature and an excitation wave-
length of 480 nm. Drug release was monitored by
drug photoluminescence over 7200 min (120 h) in
two different pH buffer mediums: pH 5.2 and pH 7.4.
Once we reached 2880 min (48 h), the pH 7.4
medium was changed for pH 5.4 medium. Intensities
of the fluorescent peaks were converted to the corre-
sponding concentrations using a calibration curve. Re-
lease rates are reported as μg/cm2 vs. time.ition procedure. a NAA pores with positively charged walls after APTES
H deposition by immersing the PSS covered substrate. d DOX loading
er contraction at pH 8.0. f DOX releases at different pH media
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Figure 3 shows environmental scanning electron micros-
copy (SEM) images of one of the fabricated NAA sam-
ples and a schematic drawing of the porous structure.
The top surface view in Fig. 3a reveals a good ordering
in a honeycomb structure of the pores in the short
range, while the cross section in Fig. 3b demonstrates
straight and parallel growth of the pores. Image analysis
results in estimated average pore diameter (dpore) value
of 150 nm, pore length (Lpore) of 15 μm, and interpore
distance (Dint) of 480 nm. The schematic drawing in
Fig. 3c illustrates the definition of these magnitudes.
Figure 4 shows SEM pictures of the top surface of a
NAA sample after different steps in the PSS/PAH depos-
ition, in order to validate the successful deposition of the
polyelectrolyte multilayer. Figure 4a corresponds to an
as-produced sample, Fig. 4b to a sample after the depos-
ition of two polyelectrolyte bilayers, while Fig. 4c corre-
sponds to a sample after the deposition of eight
polyelectrolyte bilayers. The pictures do not show a
noticeable change in pore diameter. A statistical estima-
tion of pore diameters using image processing tech-
niques was carried out; the results are included in
Additional file 1: Figure S2 A–C and Table S1. This stat-
istical estimation results in an average pore radius of
130 nm for the three pictures in Fig. 4a–c with a stand-
ard deviation of 12 nm. To further illustrate the invari-
ability in the pore diameter from the pictures, two
circles are drawn on the figures corresponding to the
maximum and minimum size obtained from this estima-
tion. The only indication from the pictures that the sur-
face is being properly modified is that the image
contrast indeed increases with the number of bilayers.
Hence, it can be assumed that there is a polyelectrolyte
coat covering the sample surface. In order to confirm
adequate infiltration and polyelectrolyte coating in the
inner pore surfaces, we imaged a cross section of the
nanopores before and after coating with polyelectrolytes
and we obtained the energy-dispersive X-ray spectros-
copy (EDX) spectra shown in Fig. 4d, e.
It can be assumed that no pore blockage occurred dur-
ing the LbL self-assembly. The use of multivalent saltFig. 3 a Top view ESEM image of NAA. b Cross-sectional SEM image of im
close-packed hexagonal and perpendicular orientated array of columnar cesuch as CaCl2 contributes to the formation of the poly-
electrolyte layer inside the nanopore owing to a stronger
polymer-chain contraction [21, 22]. The subsequent
EDX analysis of those samples shows phosphoric and
aluminum peaks due to the sample and electrolyte pres-
ence and also an oxygen peak because of the presence of
this element in the alumina sample (Al2O3). However, a
carbon peak only appeared on those samples with poly-
electrolytes (Fig. 4d). That peak could not be found in
the alumina samples without polyelectrolyte treatment
(Fig. 4e). This observation confirms the successful de-
position and insertion of both polyelectrolytes and DOX
into the pores.
After the DOX loading, samples were exposed to dif-
ferent pH media to evaluate the pH responsiveness and
influence of the number of polyelectrolyte bilayers. Once
in contact with the aqueous medium, the polyelectrolyte
multilayer swells to a certain extent, increasing its per-
meability and allowing the diffusion of the drug. The
swelling mechanism of PAH/PSS films is generally asso-
ciated to the difference in charge density of polyelectro-
lyte chains induced by a change in the pH medium.
PAH is a weak polyelectrolyte whose amino groups
become charged when the pH decreases, producing an
increase in the osmotic pressure. Consequently, water
molecules diffuse into the polyelectrolytes and the multi-
layer swells. This phenomenon, together with the elec-
trostatic repulsion between DOX and PAH/PSS
multilayer, enables the diffusion of the drug in the
medium [23].
Figure 5a compares the release profile of DOX from
samples with different number of layers at pH 5.2
and 7.4 over a period of 3000 min. As it can be seen,
there are two groups of curves: one group at pH 5.2
and another group at pH 7.4. Each group contains
three different curves: eight bilayer samples (circles),
five bilayer samples (triangles), and two bilayer sam-
ples (squares). In general terms, it can be said that
there is a massive burst release in all curves (framed
in the graph) within the first minutes. Once this first
stage has occurred, the release rate decreases causing
a curve flattening.print NAA. c Schematic representation of the alumina pores forming a
lls
Fig. 4 Environmental scanning electron microscope images of the top views a without polyelectrolyte coat, b with two polyelectrolyte bilayers,
and c with eight polyelectrolyte bilayers. Circles about 124 and 136 are drawn in the images. The EDX measurements for cross section samples
without polyelectrolyte coating (d) and with polyelectrolyte coating (e)
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leases at pH 5.2 and 7.4, respectively. The data show
that (as expected) burst release at pH 5.2 is faster
than burst release at pH 7.4. The results at pH 5.2
within the first 30 min (Fig. 5b) show that the sam-
ples with five and two bilayers release approximately
the same amount of drug, while for the eight bilayer
samples, the release is 1.4 times bigger. AfterFig. 5 a Doxorubicin (DOX) release profile for 3000 min at pH 5.2 and 7.4 f
the burst release at pH 5.2. c Nonlinear fitting for the second burst releasestabilization, at pH 5.2, the amount of released drug
is bigger for a bigger number of bilayers: samples
with eight bilayers release 1.32 times more drug than
five bilayer samples and 1.63 times more than two
bilayer samples. Instead, at pH 7.4, the release dy-
namics is different: there is not a clear correspond-
ence between the amount of released drug and the
number of bilayers, both in the burst and in theor different numbers of polyelectrolyte bilayers. b Nonlinear fitting for
at pH 7.4
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may occur due to the inhibition caused by the poly-
electrolyte contraction.
Considering relative values, taking into account that
100 % of the drug is the total amount of drug re-
leased at infinite time, the DOX released after 30 min
for samples at pH 5.2 is between four and five times
higher than that at pH 7.4 (Fig. 6a). The result is in
accordance with the result in Fig. 5. In addition, the
relative amount of released drug is not depending on
bilayer number: 90 % of the drug has been released
during the first 24 h at pH 5.2 while only 30–40 %
of the drug is released within first 24 h at pH 7.4
(Fig. 6b). At that time, release rate is reduced
gradually until it shows a stabilized profile. We can
observe that at longer times the difference between
relative released DOX at pH 7.4 and pH 5.2 is be-
coming lower. Since the liberation of the drug at pH
7.4 is slower, it is also more sustained during time.
This is the reason why the total amount of drug
release at pH 5.2 and 7.4 is becoming closer.
In Fig. 7a, a general profile of the release is shown
in order to prove the responsiveness of the DDS to
pH variation. At minute 3000, samples immersed with
the medium at pH 7.4 were immersed to a pH 5.2
medium. This change in pH triggers another burst re-
lease really similar to the first burst release in sam-
ples at pH 5.2, which demonstrates that the DDS
responds to pH modification. The amount of drug re-
leased after the stabilization in the second burst re-
lease at pH 5.2 correlates with the number of
bilayers. However, the absolute amount of DOX re-
leased in this second burst release is not reaching the
same values of the first burst release at the same pH
for all the samples. Specifically, for two bilayers, theFig. 6 a Percentage of the DOX released within the first 30 min at differen
for different pH and bilayer numbersdrug released reaches the same value as with the pre-
vious release at pH 5.2. Instead, for five bilayers, the
total amount only reaches up to 87.5 % of the drug
released in the previous experiment at pH 5.2, while
for eight bilayers, this percentage is even lower
(72.7 %).These results can also be noticeably seen in
Fig. 7c.
Figure 7b displays a detailed fitting for the second
burst release at pH 5.2. And Fig. 7c shows a
comparison between the total amounts of DOX at
the finished release time for the different samples.
In addition, total amount of encapsulated DOX was
also studied concluding that there is a proportion-
ally direct relation between the number of poly-
electrolyte bilayers and the amount of DOX released
(Fig. 7c). This relation can be observed in both pH
mediums but becomes more obvious at pH 5.2
when DOX molecules can diffuse with less
obstruction.
In order to perform a quantitative analysis of the
results during the initial stage (burst release), we
performed a fitting study of the curves by a vari-
ation of the Higuchi and Ritger-Peppas models. The
Higuchi model is an empirical model commonly
used to describe the release kinetics of drugs from
insoluble porous materials [24, 25] It is well estab-
lished and commonly used for modeling drug
release from matrix systems [25–27]. The model is
based on a square root of time-dependent process
of Fickian diffusion [28, 29]. Fick’s law of diffusion
provides the fundamentals for the description of
solute transport from matrices [30]. The Ritger-
Peppas model (also known as Korsmeyer-Peppas) is
used to fit drug release from polymeric thin films,
cylinders, and spheres [31]. The used equation is:t pH and bilayer number. b Percentage of the DOX released after 24 h
Fig. 7 a Complete release profiles of DOX from NAA coated with different polyelectrolyte bilayer numbers at pH 5.2 and 7.4 with different burst
releases framed. b Nonlinear fitting for the second burst release at pH 5.2. c Total DOX amount released for every different sample during
the monitoring





where Mt is the proportion of DOX released at a given
time t, Mt0 is the amount of released drug at the refer-
ence time t0 (1 min), t is time in minutes, and n is a
fitting parameter related to the release rate. The adjust-
ment procedure using a least squares method minimizes
the differences between the experimental and theoretical
values [32–34]. Best fit values for those different param-
eters are reported in Table 1.Table 1 Nonlinear fitting parameters for the different burst releases
First burst release, pH 5.2 8 bilayers
5 bilayers
2 bilayers
Burst release, pH 7.4 8 bilayers
5 bilayers
2 bilayers
Second burst release, pH 5.2 8 bilayers
5 bilayers
2 bilayersThe data in Table 1 is showing Mt0 , n, and release rate
which has been obtained as the first derivative of the
equation at time t0 Mt0  nð Þ. The values of Mt0 for the
first release at pH 5.2 are one order of magnitude higher
than for the first release at pH 7.4, in good agreement
with the behavior observed in Fig. 5. Furthermore, for
pH 5.2, there is a clear difference between Mt0 for eight
bilayers on one hand, and Mt0 for five and two bilayers
on the other. This result suggests that the main contri-
bution to the drug release at pH 5.2 is coming from the
outer layers. Instead, for pH 7.4, the difference betweenusing the equation Mt ¼ Mt0 tt0
 n
Mt0 n Release rate
1.84 ± 0.05 0.36 ± 0.01 0.67
1.29 ± 0.04 0.37 ± 0.01 0.48
1.47 ± 0.05 0.32 ± 0.01 0.47
0.23 ± 0.04 0.45 ± 0.05 0.11
0.10 ± 0.01 0.57 ± 0.03 0.06
0.16 ± 0.01 0.52 ± 0.02 0.08
0.24 ± 0.03 0.47 ± 0.03 0.11
0.25 ± 0.03 0.48 ± 0.03 0.12
0.17 ± 0.02 0.49 ± 0.03 0.08
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that only the drug in the outermost layer is contributing
to the release. These results are in good agreement with
the influence of pH on the amount of released drug ob-
served in Fig. 5. In what respects the value of n, it can
be seen that the values for each pH are similar for the
different number of bilayers. This indicates that the re-
lease dynamics is influenced by pH but not by the num-
ber of polyelectrolyte bilayers.
It is also interesting to note that for the second re-
lease at pH 5.2, the Mt0 and the release rate are sens-
ibly smaller than for the first release at pH 5.2. With
this, it can be concluded that, although the DDS is
sensitive to pH variation, the first release at pH 7.4
modifies the dynamics of further release events trig-
gered by such pH variation. We attribute this fact to
the availability of DOX within the polyelectrolytes. As
part of the drug, mainly from the outermost layer,
has been already released at pH 7.4, the remaining
drug from deeper layers finds it more difficult to dif-
fuse into the medium.Conclusions
Tubular NAA membranes coated with polyelectrolytes
are presented as a stimuli-responsive pH-dependent
drug delivery system (DDS). The membranes were
fabricated using a two-step anodization process that
resulted in a highly uniform pore size distribution.
These membranes are coated with a pH-responsive
polyelectrolyte and effectively loaded with DOX to
evaluate the influence of pH and of the number of
polyelectrolyte bilayers on the release dynamics.
Higher total amounts for released DOX were found
in samples immersed in acidic medium, confirming
the pH responsiveness of the DDS. The amount of re-
leased DOX in acidic medium is in correlation with
the number of polyelectrolyte bilayers, although the
increase in released drug does not scale linearly with
the number of polyelectrolyte bilayers. This suggests
that only the outer bilayers in the polyelectrolyte
structure contribute to the release at this pH. On the
other hand, when release is performed at pH 7.4, the
amount of released drug does not depend on the
number of polyelectrolyte layers, which leads to the
conclusion that only the drug nearest to the medium
is released. The quantitative analysis of the release
curves also revealed that the release dynamics (related
with the exponent n in the Ritger-Peppas model) de-
pends strongly on the pH, but the number of poly-
electrolyte layers does not influence it. If an abrupt
change in pH is applied to the DDS, from neutral to
acidic medium, a second burst release is triggered.
This second burst release shows a dynamics differentthan the first release at pH 5.2. This can be attributed
to the limited availability of drug in the outermost
layers, after the first release at pH 7.4. To conclude,
results show that nanoporous anodic alumina coated
with layer-by-layer pH-responsive polyelectrolyte has
potential applications in local drug delivery.
Additional file
Additional file 1: Supplementary information. (DOCX 481 kb)
Funding
This work is supported in part by the Spanish Ministry of Economy and
competitiveness TEC2015-71324-R (MINECO/FEDER), the Catalan authority
AGAUR 2014SGR1344, ICREA under the ICREA Academia Award.
Authors’ Contributions
MPB and LFM conceived and designed the work. MPB prepared the samples
and carried out the measurements. PF and CE assisted MPB during the
laboratory tasks. EXP, JFB, and LFM supervised the work, provided the
discussion, and revised the manuscript. All authors read and approved the
final manuscript.
Competing Interests
The authors declare that they have no competing interests.
Received: 7 May 2016 Accepted: 13 August 2016
References
1. Sinn Aw M, Kurian M, Losic D (2014) Non-eroding drug-releasing implants
with ordered nanoporous and nanotubular structures: concepts for
controlling drug release. Biomater Sci 2:10–34. doi:10.1039/C3BM60196J
2. Losic D, Simovic S (2009) Self-ordered nanopore and nanotube platforms
for drug delivery applications. Expert Opin Drug Deliv 6:1363–1381.
doi:10.1517/17425240903300857
3. Fahr A, Liu X (2007) Drug delivery strategies for poorly water-soluble drugs.
Expert Opin Drug Deliv 4:403–16. doi:10.1517/17425247.4.4.403
4. Xu H, Zhang H, Wang D et al (2015) A facile route for rapid synthesis of
hollow mesoporous silica nanoparticles as pH-responsive delivery carrier.
J Colloid Interface Sci 451:101–107. doi:10.1016/j.jcis.2015.03.057
5. Lin Y, Lin Q, Liu X et al (2015) A highly controllable electrochemical
anodization process to fabricate porous anodic aluminum oxide
membranes. Nanoscale Res Lett 10:495. doi:10.1186/s11671-015-1202-y
6. Kang H-J, Kim DJ, Park S-J et al (2007) Controlled drug release using
nanoporous anodic aluminum oxide on stent. Thin Solid Films 515:
5184–5187. doi:10.1016/j.tsf.2006.10.029
7. Santos A, Ferré-Borrull J, Pallarès J, Marsal LF (2011) Hierarchical nanoporous
anodic alumina templates by asymmetric two-step anodization. Phys Status
Solidi (a) 208:668–674. doi:10.1002/pssa.201026435
8. Santos A, Alba M, Rahman MM et al (2012) Structural tuning of
photoluminescence in nanoporous anodic alumina by hard anodization in
oxalic and malonic acids. Nanoscale Res Lett 7:228. doi:10.1186/1556-276X-7-228
9. Xifre-Perez E, Guaita-Esteruelas S, Baranowska M et al (2015) In vitro
biocompatibility of surface-modified porous alumina particles for HepG2
tumor cells: toward early diagnosis and targeted treatment. ACS Appl Mater
Interfaces 7:18600–18608. doi:10.1021/acsami.5b05016
10. Xifre-Perez E, Ferre-Borull J, Pallares J, Marsal LF (2015) Mesoporous alumina
as a biomaterial for biomedical applications. Mesoporous Biomaterials
2:13–32. doi:10.1515/mesbi-2015-0004
11. Vallet-Regí M, Balas F, Manzano M (2007) Drug confinement and delivery in
ceramic implants. Drug Metab Lett 1:37–40
12. Simovic S, Losic D, Vasilev K (2010) Controlled drug release from porous
materials by plasma polymer deposition. Chem Commun (Camb) 46:1317–9.
doi:10.1039/b919840g
13. Patermarakis G, Moussoutzanis K (1995) Electrochemical kinetic study on the
growth of porous anodic oxide films on aluminium. Electrochim Acta 40:
699–708. doi:10.1016/0013-4686(94)00347-4
Porta-i-Batalla et al. Nanoscale Research Letters  (2016) 11:372 Page 9 of 914. Marsal LF, Vojkuvka L, Formentin P et al (2009) Fabrication and optical
characterization of nanoporous alumina films annealed at different
temperatures. Opt Mater 31:860–864. doi:10.1016/j.optmat.2008.09.008
15. Vojkuvka L, Marsal LF, Ferré-Borrull J et al (2008) Self-ordered porous
alumina membranes with large lattice constant fabricated by hard
anodization. Superlattice Microst 44:577–582. doi:10.1016/j.spmi.2007.10.005
16. Hernández-Eguía LP, Ferré-Borrull J, Macias G et al (2014) Engineering
optical properties of gold-coated nanoporous anodic alumina for
biosensing. Nanoscale Res Lett 9:414. doi:10.1186/1556-276X-9-414
17. Santos A, Montero-moreno JM, Bachmann J, et al. (2011) Understanding
pore rearrangement during mild to hard transition in bilayered porous
anodic alumina membranes. ACS Appl Mater Interfaces. 1925–1932.
doi: 10.1021/am200139k
18. Masuda H, Fukuda K (1995) Ordered metal nanohole arrays made by
a two-step replication of honeycomb structures of anodic alumina.
Science 268:1466–1468. doi:10.1126/science.268.5216.1466
19. Jessensky O (1998) Self-organized formation of hexagonal pore structures in
anodic alumina. J Electrochem Soc 145:3735. doi:10.1149/1.1838867
20. Bruening ML, Dotzauer DM, Jain P, et al. (2008) Creation of functional
membranes using polyelectrolyte multilayers and polymer brushes.
Langmuir, 7663–7673. doi: 10.1021/la800179z
21. Cho Y, Lee W, Jhon YK et al (2010) Polymer nanotubules obtained by
layer-by-layer deposition within AAO-membrane templates with
sub-100-nm pore diameters. Small 6:2683–9. doi:10.1002/smll.201001212
22. Alba M, Formentín P, Ferré-Borrull J et al (2014) pH-responsive drug delivery
system based on hollow silicon dioxide micropillars coated with polyelectrolyte
multilayers. Nanoscale Res Lett 9:411. doi:10.1186/1556-276X-9-411
23. Biesheuvel PM, Mauser T, Sukhorukov GB, Möhwald H (2006)
Micromechanical theory for pH-dependent polyelectrolyte multilayer
capsule swelling. Macromolecules 39:8480–8486. doi:10.1021/ma061350u
24. Higuchi T (1961) Rate of release of medicaments from ointment bases
containing drugs in suspension. J Pharm Sci 50:874–875. doi:10.1248/
cpb.23.3288
25. Higuchi T (1963) Mechanism of sustained-action medication. Theoretical
analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm
Sci 52:1145–1149. doi:10.1002/jps.2600521210
26. Desai SJ, Singh P, Simonelli AP, Higuchi WI (1966) Investigation of factors
influencing release of solid drug dispersed in inert matrices III. J Pharm Sci
55:1230–1234. doi:10.1002/jps.2600551113
27. McInnes SJ, Irani Y, Williams KA, Voelcker NH (2012) Controlled drug delivery
from composites of nanostructured porous silicon and poly (l -lactide).
Research Article. Nanomedicine 7:995–1016
28. Iskakov RM, Kikuchi A, Okano T (2002) Time-programmed pulsatile release of
dextran from calcium-alginate gel beads coated with carboxy-n-
propylacrylamide copolymers. J Control Release 80:57–68. doi:10.1016/
S0168-3659(01)00551-X
29. Feng W, Zhou X, He C et al (2013) Polyelectrolyte multilayer functionalized
mesoporous silica nanoparticles for pH-responsive drug delivery: layer
thickness-dependent release profiles and biocompatibility. J Mater Chem B
1:5886. doi:10.1039/c3tb21193b
30. Yao F, Weiyuan JK (2011) Drug release kinetics and transport mechanisms of
nondegradable and degradable polymeric delivery systems. Expert Opin
Drug Deliv 7:429–444. doi:10.1517/17425241003602259
31. Shoaib MH, Tazeen J, Merchant H a, Yousuf RI (2006) Evaluation of drug
release kinetics from ibuprofen matrix tablets using Hpmc. Pak J Pharm Sci
19:119–124
32. Lin LY, Lee NS, Zhu J et al (2011) Tuning core vs. shell dimensions to adjust
the performance of nanoscopic containers for the loading and release of
doxorubicin. J Control Release 152:37–48. doi:10.1016/j.jconrel.2011.01.009
33. Serra L, Doménech J, Peppas NA (2006) Drug transport mechanisms and
release kinetics from molecularly designed poly(acrylic acid-g-ethylene
glycol) hydrogels. Biomaterials 27:5440–51. doi:10.1016/j.biomaterials.2006.
06.011
34. Gultepe E, Nagesha D, Casse BDF et al (2010) Sustained drug release from
non-eroding nanoporous templates. Small 6:213–216. doi:10.1002/smll.
200901736Submit your manuscript to a 
journal and beneﬁ t from:
7 Convenient online submission
7 Rigorous peer review
7 Immediate publication on acceptance
7 Open access: articles freely available online
7 High visibility within the ﬁ eld
7 Retaining the copyright to your article
    Submit your next manuscript at 7 springeropen.com
